European Open: Equities and oil rise on China reopening, US CPI in focus
Sentiment was given another boost ahead of today’s US CPI report with China continuing to scale back restrictions and suggesting international travel could be on the horizon.
Covid and Trading
Stay in step with market opportunities and get insights, actionable trade ideas and dedicated support.
IAG Q1 preview: Where next for the IAG share price?
IAG faces a major challenge as it strives to return to profit in 2022 as a myriad of headwinds plague the airline industry.
AstraZeneca Q1 preview: Where next for AstraZeneca stock?
AstraZeneca’s results will benefit from the acquisition of Alexion, but questions remain over its Covid-19 drugs and the outlook in China.
Index in focus: A50 bears in control as COVID spreads in China
Why the COVID outbreak across the country may well get worse before it gets better...
Copper selling intensifies on China
More than 2 years into the pandemic and Covid is still roiling financial markets.
Chinese yuan, stocks and commodities slump
Just when you thought the c-word was no more a thing for the markets…
BioNTech Q4 preview: Where next for BioNTech stock?
BioNTech has become a world-renowned name thanks to its Covid-19 vaccine, but how will it perform in 2022 as the pandemic continues to ease?
Asian Open: UK logs first known Omicron death
The United Kingdom has recorded the first known Omicron-related death, as the World Health Organisation warns that variant could pose as a global risk.
Asian Open: Omicron detected in around one third of US states
Sentiment remained weak on Friday with a soft employment print not helping, although futures markets are lower with reports of Omicron spreading across the US.
Asian Open: Omicron spreads to its 29th country, including the US
The Omicron continues to make waves as it now accounts for around three quarters of cases in South Africa, with the US now reporting its first case.
Risk-off returns as Moderna CEO makes glum prediction
An article in the Financial Times triggered a fresh round of selling before the European open, as Moderna’s CEO predicts vaccines will be less effective.
easyJet FY preview: Where next for the easyJet share price?
A new COVID variant threatens to cast the airline and travel industry back into turmoil as new travel restrictions are introduced. We have a look at what it could mean for easyJet ahead of its annual earnings.
New COVID strain shakes the market, is it downhill from here?
The discovery of a new COVID strain which could be vaccine resistant has rattled traders. Here we look at which markets have been most affected and what to watch for going forwards.
The information on this web site is not targeted at the general public of any particular country. It is not intended for distribution to residents in any country where such distribution or use would contravene any local law or regulatory requirement. The information and opinions in this report are for general information use only and are not intended as an offer or solicitation with respect to the purchase or sale of any currency or CFD contract. All opinions and information contained in this report are subject to change without notice. This report has been prepared without regard to the specific investment objectives, financial situation and needs of any particular recipient. Any references to historical price movements or levels is informational based on our analysis and we do not represent or warranty that any such movements or levels are likely to reoccur in the future. While the information contained herein was obtained from sources believed to be reliable, author does not guarantee its accuracy or completeness, nor does author assume any liability for any direct, indirect or consequential loss that may result from the reliance by any person upon any such information or opinions.
Futures, Options on Futures, Foreign Exchange and other leveraged products involves significant risk of loss and is not suitable for all investors. Losses can exceed your deposits. Increasing leverage increases risk. Spot Gold and Silver contracts are not subject to regulation under the U.S. Commodity Exchange Act. Contracts for Difference (CFDs) are not available for US residents. Before deciding to trade forex, commodity futures, or digital assets, you should carefully consider your financial objectives, level of experience and risk appetite. Any opinions, news, research, analyses, prices or other information contained herein is intended as general information about the subject matter covered and is provided with the understanding that we do not provide any investment, legal, or tax advice. You should consult with appropriate counsel or other advisors on all investment, legal, or tax matters. References to FOREX.com or GAIN Capital refer to StoneX Group Inc. and its subsidiaries. Please read Characteristics and Risks of Standardized Options.